[Successful treatment of eleven female Salmonella carriers with Co-soltrim (author's transl)].
Eleven female chronic Salmonella carriers were treated with the chemotherapeutic drug Co-soltrim for an average period of 19.83 weeks. The daily dose was at first twice 2 tablets and later on twice 1 tablet. Before this treatment 4 of the patients had received other chemotherapeutic drugs without lasting curative effect. The cases were in-patients of a mental hospital and it was possible to continue their observation for a follow-up period of up to 29 months after the termination of the therapy. No case relapsed. The therapy did not produce any undesirable side effects.
D000328:Adult; D000368:Aged; D002353:Carrier State / Q000188:drug therapy*; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D012475:Salmonella / Q000302:isolation & purification; D012480:Salmonella Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D014295:Trimethoprim; D013420:Sulfamethoxazole
Bericht über die erfolgreiche Behandlung von elf weiblichen Salmonellenausscheidern mit Co-soltrim.